Among them, LMP1 is a driver oncogene in nasopharyngeal carcinoma and plays an imperative role in its pathogenesis by upregulating HK2, activating the fibroblast growth factor 2/fibroblast growth factor receptor 1 signalling pathway, and increasing the expression of glucose transporter 1 through the mTORC1/NF-κB signalling pathway [74,75,76]. This evidence concerns the gene HK2 and nasopharyngeal carcinoma.